Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formulated Posterior Sub Tenon Triamcinolone in RVO Macular Edema
NCT05345808Completed
- Sponsor
- Al-Azhar University
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of triamcinolone acetonide in macular edema, sponsored by Al-Azhar University. Primary endpoints: Best corrected visual acuity at 6 months and Central macular thickness at 6 months. Started Mar 2021; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT05345808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345808.